Commure just raised $70m at a $7b valuation. The company uses AI that automates more than 85 percent of the medical billing process for hospitals and doctors' offices. It also handles other back-office work practices used to do by hand.[1]
The round was led by General Catalyst, with Sequoia Capital. Additional investors include Morgan Stanley, and the law firm Kirkland & Ellis.[1][2]
Medical billing is a massive industry. The United States spends about $1 trillion a year on healthcare administration.[1] Commure is betting that AI can take over a meaningful share of that work. Investors agreed.
What Commure Does
Commure's main product handles the insurance billing for a visit from start to finish. After a patient is seen, the software reads the visit notes, assigns the billing codes, files the claim with the insurer, fights the claim when the insurer denies it, and records the payment. It does more than 85 percent of that work without a person.[1] The industry term for it is revenue cycle management.
Commure also sells AI that writes clinical notes during the visit and an FDA-cleared diagnostics line called Athelas.[1] The software runs inside more than 500 healthcare organizations and 3,000 sites of care, including large national hospital systems, and processes tens of billions of dollars in claims a year.[1]
The customers are big. Commure sells to hospital systems and large medical groups, not to solo doctors. CEO Tanay Tandon's pitch is that AI can already do the administrative work, and that the company is already doing it across the industry.[2]
The History of Commure
Commure was founded in 2017 by Hemant Taneja, the CEO of General Catalyst, who built it inside the venture firm alongside former leaders from Google, Salesforce, and Health Catalyst.[5] Taneja has built healthcare companies this way before. He also co-founded Livongo, the diabetes-management company that merged with Teladoc Health in 2020.[6]
Commure took its current form in October 2023, when it merged with Athelas in a deal that valued the combined company at about $6 billion.[5][7] Athelas was started by Tanay Tandon and Deepika Bodapati, who met as teenagers on the science-fair circuit.[8] Tandon worked in machine learning and Bodapati in microfluidics, and they first built an at-home blood-testing device, running their first clinical trial in 2016, before the company moved into billing and revenue cycle software.[8] Tandon now runs Commure as chief executive officer, and Bodapati, his co-founder, is chief operating officer.[7][9]
The $1 Trillion Medical Billing Industry
Healthcare billing is a trillion dollar industry annually. To take a look at how big medical billing alone is I want to compare this to a few other industries
All Legal Services: $500 Billion
Movies and Film: $150 Billion
Ultra High end Art: $80 Billion
Private Education and Tutoring: $100 Billion
This makes medical billing one of the largest total addressable markets.
Commure runs billing for hundreds of organizations and does most of the work without people.[1] Investors pay infrastructure prices for software that is that embedded. General Catalyst, which led the round, has backed Commure before and called it "a generational business with the opportunity to dramatically impact the cost of care."[1]
The medical tech space is rapidly growing. Abridge reached a $5.3 billion valuation for software that writes the doctor's notes.[3] Scribes automate the front of the paperwork. Commure automates the back of it, the billing. Both ends of the same problem are getting funded at once.
What It Means for Concierge and DPC Practices
Most concierge and DPC doctors do not go through medical billing. So the primary value proposition behind Commure is unlikely to directly affect concierge practices. That said, it will augment the competitive landscape as primary care doctors who operate in traditional medicine will have less administrative burden in the long run.
The Bottom Line
Commure's raise is a clear signal that smart money in healthcare now sees administration as the one of the most expensive and most fixable part of the system. Two approaches are competing to fix it. Companies like Commure are spending billions to automate the paperwork. Concierge and DPC practices took the other path and built a model that creates far less of it. Both can win, and this round makes the cost of the old way easier to see.
NextMD lists physician-led concierge and DPC practices for patients nationwide.
Sources
Commure. (2026). Commure Raises $70M at $7B Valuation to Transform Healthcare Operations Using AI. GlobeNewswire. Read the announcement on GlobeNewswire
AI company Commure banks $70M funding round, hits $7B valuation. (2026). Fierce Healthcare. Read on Fierce Healthcare
Pearl, R. (2026). Abridge scores $300M Series E, boosting valuation to $5.3B. Fierce Healthcare. Read on Fierce Healthcare
NextMD. (2026). DPC vs Traditional Primary Care: A Real Cost Comparison. Read on NextMD
Sacra. Commure revenue, valuation & funding. Read on Sacra
Wikipedia. Hemant Taneja. Read on Wikipedia
General Catalyst. Commure and Athelas. Read on General Catalyst
Sequoia Capital. Deepika Bodapati and Tanay Tandon of Athelas: The Listeners. Read on Sequoia Capital
Commure. (2026). Inc. Names Commure's Deepika Bodapati to Its 2026 Female Founders 500 List. Read on Commure